Insulin treatment in pregnancy was introduced earlier in the HNF1A-MD group than in the GCK-hyperglycemia group, however, this difference was not statistically significant (7.50 vs. 13.00 week, p=0.640). The gene discussed is INS; the disease is Hyperglycemia.